Targeting tumor-associated macrophages to synergize tumor immunotherapy

The current treatment strategies in advanced malignancies remain limited. Notably, immunotherapies have raised hope for a successful control of these advanced diseases, but their therapeutic responses are suboptimal and vary considerably among individuals. Tumor-associated macrophages (TAMs) are a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xiaonan, Wang, Jianguo, Lu, Di, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900181/
https://www.ncbi.nlm.nih.gov/pubmed/33619259
http://dx.doi.org/10.1038/s41392-021-00484-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900181/
https://www.ncbi.nlm.nih.gov/pubmed/33619259
http://dx.doi.org/10.1038/s41392-021-00484-9

Ejemplares similares